These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34678322)

  • 1. Development of a neutralizing antibody targeting linear epitope of the envelope protein domain III of ZIKV.
    Hu H; Liu R; Li Q; Wang J; Deng Q; Lu Y; Wu Q; Chen Z; Lu J
    Virus Res; 2021 Dec; 306():198601. PubMed ID: 34678322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
    Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of mouse monoclonal antibodies targeting to distinct epitopes of Zika virus envelope protein for specific detection of Zika virus.
    Li CJ; Huang PH; Chen HW; Chang SC
    Appl Microbiol Biotechnol; 2021 Jun; 105(11):4663-4673. PubMed ID: 34043078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
    Niu X; Zhao L; Qu L; Yao Z; Zhang F; Yan Q; Zhang S; Liang R; Chen P; Luo J; Xu W; Lv H; Liu X; Lei H; Yi C; Li P; Wang Q; Wang Y; Yu L; Zhang X; Bryan LA; Davidson E; Doranz JB; Feng L; Pan W; Zhang F; Chen L
    Emerg Microbes Infect; 2019; 8(1):749-759. PubMed ID: 31130109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
    Tsuji I; Vang F; Dominguez D; Karwal L; Sanjali A; Livengood JA; Davidson E; Fouch ME; Doranz BJ; Das SC; Dean HJ
    J Virol; 2022 Jun; 96(11):e0007122. PubMed ID: 35575481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
    Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z
    Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.
    Wu Y; Li S; Du L; Wang C; Zou P; Hong B; Yuan M; Ren X; Tai W; Kong Y; Zhou C; Lu L; Zhou X; Jiang S; Ying T
    Emerg Microbes Infect; 2017 Oct; 6(10):e89. PubMed ID: 29018252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.
    Bailey MJ; Broecker F; Freyn AW; Choi A; Brown JA; Fedorova N; Simon V; Lim JK; Evans MJ; García-Sastre A; Palese P; Tan GS
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection.
    Qu P; Zhang W; Li D; Zhang C; Liu Q; Zhang X; Wang X; Dai W; Xu Y; Leng Q; Zhong J; Jin X; Huang Z
    Antiviral Res; 2018 Jun; 154():97-103. PubMed ID: 29665376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.
    Akhras S; Herrlein ML; Elgner F; Holzhauser T; Hildt E
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
    Chambers MT; Schwarz MC; Sourisseau M; Gray ES; Evans MJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes.
    Sankhala RS; Dussupt V; Donofrio G; Gromowski GD; De La Barrera RA; Larocca RA; Mendez-Rivera L; Lee A; Choe M; Zaky W; Mantus G; Jensen JL; Chen WH; Gohain N; Bai H; McCracken MK; Mason RD; Leggat D; Slike BM; Tran U; Jian N; Abbink P; Peterson R; Mendes EA; Freitas de Oliveira Franca R; Calvet GA; Bispo de Filippis AM; McDermott A; Roederer M; Hernandez M; Albertus A; Davidson E; Doranz BJ; Rolland M; Robb ML; Lynch RM; Barouch DH; Jarman RG; Thomas SJ; Modjarrad K; Michael NL; Krebs SJ; Joyce MG
    Cell Rep; 2023 Aug; 42(8):112942. PubMed ID: 37561630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
    Yang M; Dent M; Lai H; Sun H; Chen Q
    Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells.
    Lunardelli VAS; Almeida BDS; Apostolico JS; Rezende T; Yamamoto MM; Pereira SS; Bueno MFC; Pereira LR; Carvalho KI; Slhessarenko RD; de Souza Ferreira LC; Boscardin SB; Rosa DS
    Front Immunol; 2023; 14():1071041. PubMed ID: 37006270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.